The first signs that IL-15 may have been involved in the proinflammatory TH1 response to gluten came with the finding that IL-15 is heavily upregulated in the lamina propria of active CeD patients, the effector site where dendritic cells will encounter gluten peptides (65, 66). The gene discussed is IL15; the disease is cranioectodermal dysplasia.